GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LAVA Therapeutics NV (NAS:LVTX) » Definitions » Accounts Payable & Accrued Expense

LAVA Therapeutics NV (LAVA Therapeutics NV) Accounts Payable & Accrued Expense : $7.28 Mil (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is LAVA Therapeutics NV Accounts Payable & Accrued Expense?

LAVA Therapeutics NV's quarterly accounts payable & accrued expense declined from Sep. 2023 ($15.23 Mil) to Dec. 2023 ($8.74 Mil) and declined from Dec. 2023 ($8.74 Mil) to Mar. 2024 ($7.28 Mil).

LAVA Therapeutics NV's annual accounts payable & accrued expense increased from Dec. 2021 ($4.12 Mil) to Dec. 2022 ($11.80 Mil) but then declined from Dec. 2022 ($11.80 Mil) to Dec. 2023 ($8.74 Mil).


LAVA Therapeutics NV Accounts Payable & Accrued Expense Historical Data

The historical data trend for LAVA Therapeutics NV's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LAVA Therapeutics NV Accounts Payable & Accrued Expense Chart

LAVA Therapeutics NV Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Accounts Payable & Accrued Expense
1.17 2.20 4.12 11.80 8.74

LAVA Therapeutics NV Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Accounts Payable & Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.19 16.70 15.23 8.74 7.28

LAVA Therapeutics NV Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.


LAVA Therapeutics NV (LAVA Therapeutics NV) Business Description

Industry
Traded in Other Exchanges
Address
Yalelaan 62, Utrecht, UT, NLD, 3584 CM
LAVA Therapeutics NV is a biotechnology company. It is focused on transforming cancer treatment by developing a platform of novel bispecific antibodies designed to selectively induce gamma-delta T cell-mediated immunity against tumor cells.

LAVA Therapeutics NV (LAVA Therapeutics NV) Headlines

From GuruFocus

LAVA Therapeutics Announces the Appointment of Dr. Charles Morris as Chief Medical Officer

By Stock market mentor Stock market mentor 02-06-2023

LAVA Therapeutics Announces Annual Meeting of Shareholders

By PurpleRose PurpleRose 07-10-2022

LAVA Therapeutics Announces Appointment of New Directors to the Board

By Stock market mentor Stock market mentor 01-06-2023

LAVA Therapeutics Announces Two Appointments to its Board of Directors

By GuruFocusNews GuruFocusNews 07-05-2022